Page last updated: 2024-10-21

5-hydroxydecanoate and Diabetic Nephropathies

5-hydroxydecanoate has been researched along with Diabetic Nephropathies in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, B1
Shi, YQ1
Zou, JJ1
Chen, XF1
Tang, W1
Ye, F1
Liu, ZM1

Other Studies

1 other study available for 5-hydroxydecanoate and Diabetic Nephropathies

ArticleYear
High glucose stimulates cell proliferation and Collagen IV production in rat mesangial cells through inhibiting AMPK-K
    International urology and nephrology, 2017, Volume: 49, Issue:11

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cells, Cultu

2017